Skip to content
stockresearch.app
EW/History

Edwards Lifesciences (EW) valuation history

Below its usual range

As of

EW's EV/Sales of 7.3x is lower than 89% of its available weekly readings from the last five years.

EV/Sales weekly history5.9×9.7×13.6×17.4×Shading: 5-year middle halfMedian 9.8×7.3×202120232025
Share EV/Sales history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/Sales at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

EW year-end valuation history
Reading dateEV/Sales5-year rank
7.9×15%
10.5×31%
10.8×36%
8.5×9%
15.8×100%
13.0×100%
11.7×89%
8.6×70%
7.2×45%
6.9×Short history

Loading related research…

About this history

What is EW's current EV/Sales?
EW's EV/Sales of 7.3x is lower than 89% of its available weekly readings from the last five years.
What is EW's five-year median EV/Sales?
The median, or middle weekly reading, is 9.8× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology